Details for Patent: 11,324,741
✉ Email this page to a colleague
Which drugs does patent 11,324,741 protect, and when does it expire?
Patent 11,324,741 protects CONTRAVE and is included in one NDA.
This patent has six patent family members in five countries.
Summary for Patent: 11,324,741
| Title: | Methods for treating visceral fat conditions |
| Abstract: | Disclosed are methods and compositions for treating visceral fat conditions and/or metabolic syndrome using combinations of naltrexone and bupropion. |
| Inventor(s): | Tollefson; Gary D. (Indianapolis, IN) |
| Assignee: | Nalpropion Pharmaceuticals LLC (Morristown, NJ) |
| Application Number: | 15/446,933 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 11,324,741
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,324,741
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2725930 | ⤷ Sign Up | |||
| European Patent Office | 2303025 | ⤷ Sign Up | |||
| Japan | 2011521973 | ⤷ Sign Up | |||
| Japan | 2014148554 | ⤷ Sign Up | |||
| Mexico | 2010012909 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2009158114 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
